Herein, we evaluated the treatment effect of NIR‐PIT for HER2‐positive SCLC using trastuzumab and the correlation between the HER2 expression level and the efficacy of NIR‐PIT. This evidence concerns the gene ERBB2 and small cell lung carcinoma.